Since early 2020, the entire world has been facing a disastrous outbreak of the SARS-CoV-2
virus, with massive reporting of death and infections per day. Medical practitioners adopted …

COVID‐19 has spread swiftly throughout the world posing a global health emergency. The
significant numbers of deaths attributed to this pandemic have researchers battling to …

Introduction The development of a yeast-expressed recombinant protein-based vaccine
technology co-developed with LMIC vaccine producers and suitable as a COVID-19 vaccine …

The causative factor of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is continuously mutating. Interestingly, identified mutations mainly occur in the spike …

Exposure to severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) prompts
humoral immune responses in the human body. As the auxiliary diagnosis of a current …

Background Patients with chronic lymphocytic leukemia (CLL) have reduced seroconversion
rates and lower binding antibody (Ab) and neutralizing antibody (NAb) titers than healthy …

In the coming months, most American adults will have the opportunity to receive at least one
of up to five different COVID-19 vaccines produced by Operation Warp Speed and released …

Signaling pathway alterations in COVID-19 of living humans as well as therapeutic targets of
the host proteins are not clear. We analyzed 317 urine proteomes, including 86 COVID-19 …

The antibody immune response is essential for the survival of mammals. However, we still
lack a systematic understanding of the antibody repertoire. Here, we developed a proteomic …

The COVID-19 (coronavirus disease-19) pandemic affected more than 180 million people
around the globe, causing more than five million deaths as of January 2022. SARS-CoV-2 …